KOD Company Profile and Key Details

Q: Who are the executives of KOD?

Mr. John A. Borgeson CPA, M.B.A., MBA, CPASenior Vice President, Chief Financial Officer & Sec.Dr. Jason S. Ehrlich M.D., Ph.D.Chief Medical Officer & Chief Devel. OfficerDr. Michael S. Louie Ph.D.Senior Vice President of Digital Transformation & Chief Information OfficerDr. Hong LiangSenior Vice President of Discovery MedicineDr. Stephen Raillard Ph.D.Senior Vice President of Chemical Devel. & ManufacturingMs. Almas Qudrat M.Sc.Senior Vice President of Quality OperationsTracy ChienVice President & Corporation ControllerMr. John A. Borgeson CPA, CPA, M.B.A., MBASenior Vice President, Chief Financial Officer & Sec.Dr. J. Pablo Velazquez-Martin M.D.Senior Vice President of Clinical Research & Translational MedicineDr. Victor Perlroth M.D.Co-Founder, Chairman, Chief Executive Officer & PresMr. John A. Borgeson C.P.A., CPA, M.B.A., MBASenior Vice President, Chief Financial Officer & Sec.

NASDAQ : KOD

Kodiak Sciences

$36.36

-1.14-3.04%

At Close 4:00 PM

57.47

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Kodiak Sciences Inc. (KOD) stock declined over -3.04%, trading at $36.36 on NASDAQ, down from the previous close of $37.50. The stock opened at $37.60, fluctuating between $36.23 and $37.82 in the recent session.

Stock Snapshot

37.5

Prev. Close

2.28B

Market Cap

36.225

Day Low

-8.72

P/E Ratio

-4.17

EPS (TTM)

-3.73

Cash Flow per Share

37.6

Open

62.58M

Number of Shares

37.815

Day High

92.35%

Free Float in %

5.06

Book Value

460.06K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 03, 2026	37.60	37.82	36.20	36.36	459.77K
Sep 02, 2026	37.44	39.54	36.61	37.50	507.38K
Sep 01, 2026	37.01	38.10	36.70	37.06	391.55K
Aug 31, 2026	37.28	37.76	35.50	37.35	1.15M
Aug 28, 2026	38.73	39.62	37.40	37.72	468.97K
Aug 27, 2026	39.37	40.11	38.65	39.12	474.89K
Aug 26, 2026	39.94	40.03	38.40	39.33	296.81K
Aug 25, 2026	37.99	39.68	37.70	39.46	571.31K
Aug 24, 2026	38.33	38.90	36.46	37.22	717.48K
Aug 21, 2026	40.39	40.90	37.99	38.33	509.01K
Aug 20, 2026	39.50	40.52	38.69	39.84	486.62K
Aug 19, 2026	41.72	41.72	39.30	40.07	595.65K
Aug 18, 2026	40.06	40.94	39.06	40.65	623.74K
Aug 17, 2026	40.57	43.04	39.87	40.98	628.13K
Aug 14, 2026	37.40	42.00	36.35	41.35	746.98K
Aug 13, 2026	43.82	44.50	39.15	39.98	806.63K
Aug 12, 2026	43.34	43.64	42.22	43.41	382.97K
Aug 11, 2026	43.47	43.80	41.21	42.11	515.91K
Aug 10, 2026	44.86	46.09	42.77	43.40	537.25K
Aug 07, 2026	46.12	46.87	45.11	45.37	471.9K

Contact Details

Palo Alto, CA 94304

United States

https://kodiak.com 650 281 0850

About Company

Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.

Stock Peers

ARGX

-1.91-0.18%

argenx SE$1,053.46 REGN

-8.56-1.00%

Regeneron Pharmaceuticals, Inc.$843.47 VRTX

1.21+0.22%

Vertex Pharmaceuticals Incorporated$557.96 MDGL

-4.32-0.79%

Madrigal Pharmaceuticals, Inc.$542.61 UTHR

-1.78-0.36%

United Therapeutics Corporation$490.24 KRYS

2.24+0.61%

Krystal Biotech, Inc.$371.47 ONC

0.9+0.25%

BeOne Medicines AG$362.68 PRAX

-2.35-0.66%

Praxis Precision Medicines, Inc.$355.15 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

2.82+0.98%

Ligand Pharmaceuticals Incorporated$289.74

Frequently Asked Questions

What is the current Kodiak Sciences Inc. (KOD) stock price?

Kodiak Sciences Inc. (NASDAQ: KOD) stock price is $36.36 in the last trading session. During the trading session, KOD stock reached the peak price of $37.82 while $36.23 was the lowest point it dropped to. The percentage change in KOD stock occurred in the recent session was -3.04% while the dollar amount for the price change in KOD stock was - $1.14.

KOD's industry and sector of operation?

The NASDAQ listed KOD is part of Biotechnology industry that operates in the broader Healthcare sector. Kodiak Sciences Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of KOD?

Mr. John A. Borgeson CPA, M.B.A., MBA, CPA
Senior Vice President, Chief Financial Officer & Sec.
Dr. Jason S. Ehrlich M.D., Ph.D.
Chief Medical Officer & Chief Devel. Officer
Dr. Michael S. Louie Ph.D.
Senior Vice President of Digital Transformation & Chief Information Officer
Dr. Hong Liang
Senior Vice President of Discovery Medicine
Dr. Stephen Raillard Ph.D.
Senior Vice President of Chemical Devel. & Manufacturing
Ms. Almas Qudrat M.Sc.
Senior Vice President of Quality Operations
Tracy Chien
Vice President & Corporation Controller
Mr. John A. Borgeson CPA, CPA, M.B.A., MBA
Senior Vice President, Chief Financial Officer & Sec.
Dr. J. Pablo Velazquez-Martin M.D.
Senior Vice President of Clinical Research & Translational Medicine
Dr. Victor Perlroth M.D.
Co-Founder, Chairman, Chief Executive Officer & Pres
Mr. John A. Borgeson C.P.A., CPA, M.B.A., MBA
Senior Vice President, Chief Financial Officer & Sec.

How KOD did perform over past 52-week?

KOD's closing price is 338.07% higher than its 52-week low of $8.55 where as its distance from 52-week high of $47.84 is -24%.

How many employees does KOD have?

Number of KOD employees currently stands at 141.

Link for KOD official website?

Official Website of KOD is: https://kodiak.com

How do I contact KOD?

KOD could be contacted at phone 650 281 0850 and can also be accessed through its website. KOD operates from 1200 Page Mill Road, Palo Alto, CA 94304, United States.

How many shares of KOD are traded daily?

KOD stock volume for the day was 460.06K shares. The average number of KOD shares traded daily for last 3 months was 693.26K.

What is the market cap of KOD currently?

The market value of KOD currently stands at $2.28B with its latest stock price at $36.36 and 62.58M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	141
Beta	2.21
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	141
Beta	2.21
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

KOD Company Profile and Key Details

Kodiak Sciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics